P

Inventor

OKSCHE ALEXANDER

DE11 patents
⚠️ This page may combine multiple inventors who share the name “OKSCHE ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HARM REDUCTION THERAPEUTICS INC

3 patents
US11020343B2Jun 1, 2021

Intranasal pharmaceutical dosage forms comprising naloxone

HARM REDUCTION THERAPEUTICS INC7 citations79
US11806428B2Nov 7, 2023

Intranasal pharmaceutical dosage forms comprising naloxone

HARM REDUCTION THERAPEUTICS INC2 citations68
US12458591B2Nov 4, 2025

Intranasal pharmaceutical dosage forms comprising naloxone

HARM REDUCTION THERAPEUTICS INC0 citations57

PURDUE PHARMA LP

2 patents
US9370512B2Jun 21, 2016

Buprenorphine-wafer for drug substitution therapy

PURDUE PHARMA LP2 citations60
US9763931B2Sep 19, 2017

Buprenorphine-wafer for drug substitution therapy

PURDUE PHARMA LP0 citations49

EURO CELTIQUE SA

2 patents
US10898479B2Jan 26, 2021

Dihydroetorphine for the provision of pain relief and anaesthesia

EURO CELTIQUE SA0 citations58
US10071089B2Sep 11, 2018

Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

EURO CELTIQUE SA0 citations45

OKSCHE ALEXANDER

2 patents
US9101625B2Aug 11, 2015

Buprenorphine-wafer for drug substitution therapy

OKSCHE ALEXANDER3 citations57
US9782359B2Oct 10, 2017

Opioid composition for treating skin lesions

OKSCHE ALEXANDER0 citations29

FORSCHUNGSVERBUND BERLIN EV

1 patent
US7863432B2Jan 4, 2011

Nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein

FORSCHUNGSVERBUND BERLIN EV3 citations56

RHODES PHARMACEUTICALS LP

1 patent
US9861628B2Jan 9, 2018

Buprenorphine-wafer for drug substitution therapy

RHODES PHARMACEUTICALS LP0 citations49